<VariationArchive VariationID="977138" VariationName="NM_031844.3(HNRNPU):c.1664del (p.Leu555fs)" VariationType="Deletion" Accession="VCV000977138" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2020-08-23" MostRecentSubmission="2020-08-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="965272" VariationID="977138">
      <GeneList>
        <Gene Symbol="HNRNPU" FullName="heterogeneous nuclear ribonucleoprotein U" GeneID="3192" HGNC_ID="HGNC:5048" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q44</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="244850297" stop="244864543" display_start="244850297" display_stop="244864543" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="245013601" stop="245027826" display_start="245013601" display_stop="245027826" Strand="-" />
          </Location>
          <OMIM>602869</OMIM>
          <Haploinsufficiency last_evaluated="2016-09-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=HNRNPU">Some evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2016-09-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=HNRNPU">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_031844.3(HNRNPU):c.1664del (p.Leu555fs)</Name>
      <CanonicalSPDI>NC_000001.11:244856806:A:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q44</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="244856807" stop="244856807" display_start="244856807" display_stop="244856807" variantLength="1" positionVCF="244856806" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="245020109" stop="245020109" display_start="245020109" display_stop="245020109" variantLength="1" positionVCF="245020108" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>L536fs</ProteinChange>
      <ProteinChange>L555fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.245020109del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.245020109del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.244856807del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.244856807del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_042184.1" sequenceAccession="NG_042184" sequenceVersion="1" change="g.12719del">
            <Expression>NG_042184.1:g.12719del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004501.3" sequenceAccession="NM_004501" sequenceVersion="3" change="c.1607del">
            <Expression>NM_004501.3:c.1607del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004492.2" sequenceAccession="NP_004492" sequenceVersion="2" change="p.Leu536fs">
            <Expression>NP_004492.2:p.Leu536fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_031844.3" sequenceAccession="NM_031844" sequenceVersion="3" change="c.1664del" MANESelect="true">
            <Expression>NM_031844.3:c.1664del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_114032.2" sequenceAccession="NP_114032" sequenceVersion="2" change="p.Leu555fs">
            <Expression>NP_114032.2:p.Leu555fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1680691597" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_031844.3(HNRNPU):c.1664del (p.Leu555fs) AND Developmental and epileptic encephalopathy, 54" Accession="RCV001254678" Version="3">
        <ClassifiedConditionList TraitSetID="35377">
          <ClassifiedCondition DB="MedGen" ID="C4479319">Developmental and epileptic encephalopathy, 54</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-05-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-05-28" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-08-23" MostRecentSubmission="2020-08-23">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">28944577</ID>
        </Citation>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/2934363e-009c-4a52-ba06-1f9636e757a6</URL>
        </Citation>
        <ConditionList>
          <TraitSet ID="35377" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="37053" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Epileptic encephalopathy, early infantile, 54</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Developmental and epileptic encephalopathy, 54</ElementValue>
                <XRef ID="MONDO:0033363" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DEE54</ElementValue>
                <XRef Type="MIM" ID="617391" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EIEE54</ElementValue>
                <XRef Type="MIM" ID="617391" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16225" />
                <XRef ID="16225" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">HNRNPU-related neurodevelopmental disorder (HNRNPU-NDD) is characterized by developmental delay and intellectual disability – typically moderate to severe – with speech and language delay and/or absent speech. Affected individuals may also display autistic features. There may be feeding difficulties during the neonatal period as well as hypotonia, which often remains lifelong. Dysmorphic features have been described but they are nonspecific. Affected individuals are likely to experience seizures (most commonly tonic-clonic or absence) that may be refractory to treatment. Nonspecific brain MRI findings include ventriculomegaly and thinning of the corpus callosum. Less common findings include cardiac abnormalities, strabismus, undescended testes in males, renal anomalies, and skeletal features, including joint laxity, polydactyly, and scoliosis. Rarely, abnormal breathing patterns, including hyperventilation and apnea, may be present and can lead to sleep disturbance.</Attribute>
                <XRef ID="NBK578573" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">35274911</ID>
                <ID Source="BookShelf">NBK578573</ID>
              </Citation>
              <XRef ID="C4479319" DB="MedGen" />
              <XRef ID="MONDO:0033363" DB="MONDO" />
              <XRef Type="MIM" ID="617391" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2825141" SubmissionDate="2020-05-29" DateLastUpdated="2020-08-23" DateCreated="2020-08-23">
        <ClinVarSubmissionID localKey="2934363e-009c-4a52-ba06-1f9636e757a6" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV001430732" DateUpdated="2020-08-23" DateCreated="2020-08-23" Type="SCV" Version="1" SubmitterName="Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard" OrgID="506627" OrganizationCategory="laboratory" OrgAbbreviation="Broad RDG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-05-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">28944577</ID>
          </Citation>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/2934363e-009c-4a52-ba06-1f9636e757a6</URL>
          </Citation>
          <Comment>The heterozygous p.Leu555ArgfsTer51 variant in HNRNPU was identified by our study in an individual with early infantile epileptic encephalopathy (PMID: 28944577). Trio exome analysis showed this variant to be de novo. This variant was absent from large population studies. This variant is predicted to cause a frameshift, which alters the proteinâ€™s amino acid sequence beginning at position 555 and leads to a premature termination codon 51 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Heterozygous loss of function of the HNRNPU gene is an established disease mechanism in early infantile epileptic encephalopathy. In summary, this variant meets criteria to be classified as pathogenic for early infantile epileptic encephalopathy in an autosomal dominant manner based on the predicted impact of the variant and de novo inheritance. ACMG/AMP Criteria applied: PS2, PVS1, PM2 (Richards 2015).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HNRNPU" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_031844.3:c.1664del</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.11:g.244856807del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0033363" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7518114</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2825141" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0033363" MappingRef="MONDO">
        <MedGen CUI="C4479319" Name="Developmental and epileptic encephalopathy, 54" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

